We are live on ! Find out more
RARX

Ra Pharmaceuticals, Inc. Common Stock
RARX

Delisted

RARX was delisted on the 1st of April, 2020.

Back to rankings

1 hedge funds and large institutions have $32K invested in Ra Pharmaceuticals, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 142 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 144 → 1 (-143)

100% less funds holding in top 10

Funds holding in top 10: 11 → 0 (-11)

100% less capital invested

Capital invested by funds: $2.47B → $32K (-$2.47B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 142

Holders
1
Holders Change
-143
Holders Change %
-99.31%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-11
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
142
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
NMC
NEA Management Company
Maryland
-$295M
2
RCM
RA Capital Management
Massachusetts
-$233M
3
BlackRock
BlackRock
New York
-$213M
4
BBA
Baker Bros. Advisors
New York
-$101M
5
AAM
Alpine Associates Management
Florida
-$96.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
Daiwa Securities Group
1
Daiwa Securities Group
Japan
$32K – – –
NMC
2
NEA Management Company
Maryland
– -$295M -6,138,797 Closed
RCM
3
RA Capital Management
Massachusetts
– -$233M -4,858,260 Closed
BlackRock
4
BlackRock
New York
– -$213M -4,444,070 Closed
BBA
5
Baker Bros. Advisors
New York
– -$101M -2,093,839 Closed
AAM
6
Alpine Associates Management
Florida
– -$96.3M -2,005,600 Closed
HI
7
HBK Investments
Texas
– -$96.2M -2,004,042 Closed
Vanguard Group
8
Vanguard Group
Pennsylvania
– -$94.6M -1,970,034 Closed
MF
9
Magnetar Financial
Illinois
– -$80.6M -1,679,600 Closed
JP Morgan Chase
10
JP Morgan Chase
New York
– -$79.8M -1,661,842 Closed
State Street
11
State Street
Massachusetts
– -$79M -1,645,236 Closed
FCM
12
Farallon Capital Management
California
– -$69.1M -1,440,000 Closed
WCMNY
13
Westchester Capital Management (New York)
New York
– -$60.8M -1,266,444 Closed
AA
14
AQR Arbitrage
Connecticut
– -$57.2M -1,190,437 Closed
VI
15
Versor Investments
New York
– -$53.2M -1,108,845 Closed
Barclays
16
Barclays
United Kingdom
– -$52.7M -1,096,869 Closed
OP
17
Omni Partners
United Kingdom
– -$50.5M -1,052,744 Closed
Goldman Sachs
18
Goldman Sachs
New York
– -$48.7M -1,014,822 Closed
PCM
19
Pentwater Capital Management
Florida
– -$47M -978,700 Closed
TAL
20
TIG Advisors LLC
New York
– -$37.4M -778,714 Closed
Citigroup
21
Citigroup
New York
– -$36.2M -754,909 Closed
GF
22
Gabelli Funds
New York
– -$30.6M -637,908 Closed
BHMP
23
Bardin Hill Management Partners
New York
– -$29.3M -609,614 Closed
Geode Capital Management
24
Geode Capital Management
Massachusetts
– -$24.7M -513,937 Closed
CS
25
Credit Suisse
Switzerland
– -$23.4M -486,872 Closed
1
2 3 4 5

RARX Hedge Fund Activity: Q2 2020 in Review

1 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Ra Pharmaceuticals, Inc. Common Stock (RARX) for Q2 2020, worth a combined $32K — down 100% from $2.47B a quarter earlier.

Sellers outnumbered buyers: 142 funds closed out of RARX and 0 opened new positions — a net loss of 142 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was NEA Management Company, exiting entirely with an estimated $295M sold.

  • 1 institutional investor held Ra Pharmaceuticals, Inc. Common Stock (RARX) as of Q2 2020, down from 144 in Q1 2020.
  • Funds reported $32K of Ra Pharmaceuticals, Inc. Common Stock stock for Q2 2020, down 100% quarter-over-quarter.
  • 0 funds opened new Ra Pharmaceuticals, Inc. Common Stock positions in Q2 2020 and 142 closed out, a net change of -142 holders.
  • The largest Ra Pharmaceuticals, Inc. Common Stock seller in Q2 2020 was NEA Management Company, an estimated $295M sold.

Based on aggregated 13F filings for Q2 2020.